| Literature DB >> 34206751 |
Suriya Rehman1, Munirah A Almessiere2,3, Suhailah S Al-Jameel4, Uzma Ali5, Yassine Slimani2, Nedaa Tashkandi6, Najat S Al-Saleh7, Ayyar Manikandan8, Firdos Alam Khan9, Ebtesam A Al-Suhaimi10, Abdulhadi Baykal6.
Abstract
The current study offers an efficient design of novel nanoparticle microspheres (MCs) using a hydrothermal approach. The Co0.5Ni0.5GaxFe2-xO4 (0.0 ≤ x ≤ 1.0) MCs were prepared by engineering the elements, such as cobalt (Co), nickel (Ni), iron (Fe), and gallium (Ga). There was a significant variation in MCs' physical structure and surface morphology, which was evaluated using energy dispersive X-ray analysis (EDX), X-ray diffractometer (XRD), high-resolution transmission electron microscopy (HR-TEM), and scanning electron microscope (SEM). The anti-proliferative activity of MCs was examined by MTT assay and DAPI staining using human colorectal carcinoma cells (HCT-116), human cervical cancer cells (HeLa), and a non-cancerous cell line-human embryonic kidney cells (HEK-293). Post 72 h treatment, MCs caused a dose dependent inhibition of growth and proliferation of HCT-116 and HeLa cells. Conversely, no cytotoxic effect was observed on HEK-293 cells. The anti-fungal action was assessed by the colony forming units (CFU) technique and SEM, resulting in the survival rate of Candida albicans as 20%, with severe morphogenesis, on treatment with MCs x = 1.0. These findings suggest that newly engineered microspheres have the potential for pharmaceutical importance, in terms of infectious diseases and anti-cancer therapy.Entities:
Keywords: Keywords: nanomaterial synthesis; anti-cancer agents; anti-fungal; microspheres
Year: 2021 PMID: 34206751 DOI: 10.3390/pharmaceutics13070962
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321